Latest Lead News

EVE Health Group has begun distributing Dyspro™, a novel cannabinoid-based treatment for dysmenorrhoea and endometriosis, through a national telehealth partnership. This launch targets a significant unmet need in women’s health with a growing global market.

Viva Energy announces the resignation of Jevan Bouzo as CEO of its Convenience and Mobility business, appointing Jennifer Gray as interim leader while searching for a permanent replacement.

Everlast Minerals Ltd has issued a Replacement Prospectus for a $4-6 million ASX IPO to fund its mineral sands projects in Bangladesh, focusing on advancing the Gaibandha project towards commercial production.

ChemX Materials Limited has entered voluntary administration following a turbulent quarter marked by convertible note amendments, a trading suspension, and ongoing funding challenges.

XPON Technologies announces a significant leadership reshuffle with founder Matt Forman stepping down as CEO due to health reasons, while Mark Simari assumes the role of Executive Chair amid strategic growth initiatives.

Kogan.com Ltd has announced a fully franked ordinary dividend of 7 cents per share for the six months ending June 2025, alongside details of its Dividend Reinvestment Plan pricing.

CLINUVEL Pharmaceuticals has presented compelling new case studies demonstrating the efficacy of SCENESSE® in treating vitiligo, showing significant and stable repigmentation in patients. These findings, shared at the EADV conference, hint at a potential breakthrough for a condition with limited treatment options.

Argent Minerals has reported outstanding high-grade silver and polymetallic mineralisation from diamond drillhole AKDD208 at its Kempfield project, revealing extensive zones that could significantly boost the resource base.

FSA Group Limited has priced its second asset-backed securities deal, raising $300 million secured by automobile and equipment receivables. The transaction, arranged by National Australia Bank, signals growing momentum in the company's securitisation strategy.

Resimac Group has successfully settled a A$1 billion non-conforming residential mortgage backed securities transaction, marking its second such bond issuance this year. The deal attracted strong domestic and offshore investor interest, reinforcing Resimac’s diversified funding strategy.

Challenger Limited has announced the Dividend Reinvestment Plan (DRP) issue price for its final 2025 dividend at $8.3615 per share, with a modest 2% participation rate leading to the issuance of approximately 266,000 new shares.

Xamble Group Limited has successfully closed a partially underwritten rights issue, raising approximately A$1.36 million to accelerate its digital marketing platform expansion in Southeast Asia.